Vereinigtes Königreich - Englisch - MHRA (Medicines & Healthcare Products Regulatory Agency)

pierre fabre ltd - vinflunine ditartrate - solution for infusion - 25mg/1ml

Vereinigtes Königreich - Englisch - MHRA (Medicines & Healthcare Products Regulatory Agency)

pierre fabre ltd - vinflunine ditartrate - solution for infusion - 25mg/1ml

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

pierre fabre usa inc. - hydroquinone (unii: xv74c1n1ae) (hydroquinone - unii:xv74c1n1ae) - glytone skin lightening cream is indicated for the gradual lightening of hyperpigmented skin conditions such as chloasma, melasma, freckles, senile lentigines, and other unwanted areas of melanin hyperpigmentation. prior history of sensitivity or allergic reaction to this product or any of its ingredients. the safety of topical hydroquinone use during pregnancy or in children (12 years and under) has not been established.

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

pierre fabre usa inc. - hydroquinone (unii: xv74c1n1ae) (hydroquinone - unii:xv74c1n1ae), avobenzone (unii: g63qqf2nox) (avobenzone - unii:g63qqf2nox), octinoxate (unii: 4y5p7mud51) (octinoxate - unii:4y5p7mud51), octocrylene (unii: 5a68wgf6wm) (octocrylene - unii:5a68wgf6wm), oxybenzone (unii: 95oos7ve0y) (oxybenzone - unii:95oos7ve0y) - glytone sunvanish is indicated for the gradual lightening of hyperpigmented skin conditions such as chloasma, melasma, freckles, senile lentigines, and other unwanted areas of melanin hyperpigmentation. prior history of sensitivity or allergic reaction to this product or any of its ingredients. the safety of topical hydroquinone use during pregnancy or in children (12 years and under) has not been established.

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

pierre fabre usa inc. - hydroquinone (unii: xv74c1n1ae) (hydroquinone - unii:xv74c1n1ae) - glytone skin lightening gel is indicated for the gradual lightening of hyperpigmented skin conditions such as chloasma, melasma, freckles, senile lentigines, and other unwanted areas of melanin hyperpigmentation. prior history of sensitivity or allergic reaction to this product or any of its ingredients. the safety of topical hydroquinone use during pregnancy or in children (12 years and under) has not been established.

Irland - Englisch - HPRA (Health Products Regulatory Authority)

pierre fabre ltd - vinorelbine tartrate - concentrate for solution for infusion - 10 base mg/ml - vinca alkaloids and analogues; vinorelbine

Irland - Englisch - HPRA (Health Products Regulatory Authority)

pierre fabre medicament - carbocisteine - oral solution - 250/5 mg/ml - carbocisteine

Malta - Englisch - Medicines Authority

pierre fabre medicament 45 place abel gance, 92100 boulogne, france - vinorelbine tartrate - concentrate for solution for infusion - vinorelbine tartrate 10 mg/ml - antineoplastic agents

Irland - Englisch - HPRA (Health Products Regulatory Authority)

pierre fabre medicament - vinorelbine - concentrate for solution for infusion - 10 milligram(s)/millilitre - vinca alkaloids and analogues; vinorelbine

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

pierre fabre medicament australia pty ltd - vinflunine ditartrate -